Trial · NCT03643952
Results by group48
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 48
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With an Adverse Event | Daptomycin | 55.6 | Percentage of Participants | ||
| Percentage of Participants That Discontinued Study Treatment Due to an Adverse Event (AE) | Daptomycin | 0 | Percentage of Participants | ||
| Percentage of Participants With Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Who Experienced Clinical Success | Daptomycin (MRSA With cSSTI) | 85.7 | 95% Confidence Interval 42.1 to 99.6 | Percentage of Participants | |
| Percentage of Participants With Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Who Experienced Clinical Success | Daptomycin (MRSA With Bacteremia) | 100 | 95% Confidence Interval 2.5 to 100 | Percentage of Participants | |
| Percentage of Participants With MRSA Infections Who Experienced a Microbiological Response | Daptomycin (MRSA With cSSTI) | 71.4 | 95% Confidence Interval 29.0 to 96.3 | Percentage of Participants | |
| Percentage of Participants With MRSA Infections Who Experienced a Microbiological Response | Daptomycin (MRSA With Bacteremia) | 100 | 95% Confidence Interval 2.5 to 100 | Percentage of Participants | |
| Area Under the Concentration Time Curve From 0 to 24 Hours (AUC0-24hr) of Daptomycin | Daptomycin (cSSTI) | Age Category 1-<2 years | 574 | Standard Deviation 99.1 | µg·hr/mL |
| Area Under the Concentration Time Curve From 0 to 24 Hours (AUC0-24hr) of Daptomycin | Daptomycin (Bacteremia) | Age Category 1-<2 years | 502 | Standard Deviation 0 | µg·hr/mL |
| Area Under the Concentration Time Curve From 0 to 24 Hours (AUC0-24hr) of Daptomycin | Daptomycin (cSSTI) | Age Category 2-6 years | 431 | Standard Deviation 53.6 | µg·hr/mL |
| Area Under the Concentration Time Curve From 0 to 24 Hours (AUC0-24hr) of Daptomycin | Daptomycin (cSSTI) | Age Category 7-11 years | 409 | Standard Deviation 143 | µg·hr/mL |
| Area Under the Concentration Time Curve From 0 to 24 Hours (AUC0-24hr) of Daptomycin | Daptomycin (Bacteremia) | Age Category 7-11 years | 599 | Standard Deviation 0 | µg·hr/mL |
| Area Under the Concentration Time Curve From 0 to 24 Hours (AUC0-24hr) of Daptomycin | Daptomycin (cSSTI) | Age Category 12-17 years | 316 | Standard Deviation 18.2 | µg·hr/mL |
| Area Under the Concentration Time Curve From 0 to 24 Hours (AUC0-24hr) of Daptomycin | Daptomycin (Bacteremia) | Age Category 12-17 years | 422 | Standard Deviation 0 | µg·hr/mL |
| Maximum Plasma Concentration (Cmax) of Daptomycin | Daptomycin (cSSTI) | Age Category 1-<2 years | 91.7 | Standard Deviation 6.66 | μg/mL |
| Maximum Plasma Concentration (Cmax) of Daptomycin | Daptomycin (Bacteremia) | Age Category 1-<2 years | 104 | Standard Deviation 8.70 | μg/mL |
| Maximum Plasma Concentration (Cmax) of Daptomycin | Daptomycin (cSSTI) | Age Category 2-6 years | 80.3 | Standard Deviation 4.48 | μg/mL |
| Maximum Plasma Concentration (Cmax) of Daptomycin | Daptomycin (cSSTI) | Age Category 7-11 years | 64.4 | Standard Deviation 15.1 | μg/mL |
| Maximum Plasma Concentration (Cmax) of Daptomycin | Daptomycin (Bacteremia) | Age Category 7-11 years | 73.1 | Standard Deviation 0 | μg/mL |
| Maximum Plasma Concentration (Cmax) of Daptomycin | Daptomycin (cSSTI) | Age Category 12-17 years | 49.3 | Standard Deviation 1.33 | μg/mL |
| Maximum Plasma Concentration (Cmax) of Daptomycin | Daptomycin (Bacteremia) | Age Category 12-17 years | 94.0 | Standard Deviation 0 | μg/mL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03643952/results